Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (51-60 of 372) with videos related to

Pageof 38
Sort By:
Gastroenterology|March 24, 2012
Interferon-free oral therapy for hepatitis C: "faraway, so close!"Alessio Aghemo, Massimo Colombo
Journal of Hepatology|May 17, 2017
Controlling liver cancer mortality on a global scale: Still a long way to goMassimo Colombo, Patrick Maisonneuve
Nature Reviews. Gastroenterology & Hepatology|May 13, 2018
HCV therapy and risk of liver cancer recurrence: who to treat?Massimo Colombo, Vincenzo Boccaccio
Gastroenterology|October 29, 2011
Treatment of chronic hepatitis delta: mission impossible?Raffaella Romeo, Massimo Colombo
Hepatology (Baltimore, Md.)|April 23, 2014
Vitamin D deficiency and liver cancer: more than just an epidemiological association?Massimo Colombo, Angelo Sangiovanni
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 16, 2021
Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosisAngelo Sangiovanni, Massimo Colombo
Chinese Clinical Oncology|April 6, 2015
Guidelines for the management of hepatocellular carcinoma: still in need of standardizationAngelo Sangiovanni, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2016
Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?Roberta D'Ambrosio, Massimo Colombo
Gastroenterology|December 23, 2014
Treatment of recurrent hepatitis C with interferon-free regimens: better starting earlyFederica Invernizzi, Massimo Colombo
Toxicology|December 31, 2002
The natural history of hepatocellular carcinomaRaffaella Romeo, Massimo Colombo
Pageof 38

Showing results (51-60 of 372) with videos related to

Sort By:
Pageof 38
Gastroenterology|March 24, 2012
Interferon-free oral therapy for hepatitis C: "faraway, so close!"Alessio Aghemo, Massimo Colombo
Journal of Hepatology|May 17, 2017
Controlling liver cancer mortality on a global scale: Still a long way to goMassimo Colombo, Patrick Maisonneuve
Nature Reviews. Gastroenterology & Hepatology|May 13, 2018
HCV therapy and risk of liver cancer recurrence: who to treat?Massimo Colombo, Vincenzo Boccaccio
Gastroenterology|October 29, 2011
Treatment of chronic hepatitis delta: mission impossible?Raffaella Romeo, Massimo Colombo
Hepatology (Baltimore, Md.)|April 23, 2014
Vitamin D deficiency and liver cancer: more than just an epidemiological association?Massimo Colombo, Angelo Sangiovanni
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|March 16, 2021
Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosisAngelo Sangiovanni, Massimo Colombo
Chinese Clinical Oncology|April 6, 2015
Guidelines for the management of hepatocellular carcinoma: still in need of standardizationAngelo Sangiovanni, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|March 4, 2016
Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?Roberta D'Ambrosio, Massimo Colombo
Gastroenterology|December 23, 2014
Treatment of recurrent hepatitis C with interferon-free regimens: better starting earlyFederica Invernizzi, Massimo Colombo
Toxicology|December 31, 2002
The natural history of hepatocellular carcinomaRaffaella Romeo, Massimo Colombo
Pageof 38